Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Chemphyschem ; 12(3): 609-26, 2011 Feb 25.
Article in English | MEDLINE | ID: mdl-21337485

ABSTRACT

A fluorescence lifetime imaging (FLIM) technology platform intended to read out changes in Förster resonance energy transfer (FRET) efficiency is presented for the study of protein interactions across the drug-discovery pipeline. FLIM provides a robust, inherently ratiometric imaging modality for drug discovery that could allow the same sensor constructs to be translated from automated cell-based assays through small transparent organisms such as zebrafish to mammals. To this end, an automated FLIM multiwell-plate reader is described for high content analysis of fixed and live cells, tomographic FLIM in zebrafish and FLIM FRET of live cells via confocal endomicroscopy. For cell-based assays, an exemplar application reading out protein aggregation using FLIM FRET is presented, and the potential for multiple simultaneous FLIM (FRET) readouts in microscopy is illustrated.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Proteins/analysis , Cell Line , Drug Evaluation, Preclinical , Fluorescent Dyes/chemistry , Green Fluorescent Proteins/chemistry , Humans , Microscopy, Fluorescence , Protein Binding , Rhodamines/chemistry , gag Gene Products, Human Immunodeficiency Virus/analysis
2.
Bioorg Med Chem Lett ; 21(21): 6586-90, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21925880

ABSTRACT

We report the use of fragment screening and fragment based drug design to develop a PI3γ kinase fragment hit into a lead. Initial fragment hits were discovered by high concentration biochemical screening, followed by a round of virtual screening to identify additional ligand efficient fragments. These were developed into potent and ligand efficient lead compounds using structure guided fragment growing and merging strategies. This led to a potent, selective, and cell permeable PI3γ kinase inhibitor with good metabolic stability that was useful as a preclinical tool compound.


Subject(s)
Drug Discovery , Phosphoinositide-3 Kinase Inhibitors , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Cell Membrane Permeability/drug effects , Drug Stability , Models, Molecular , Structure-Activity Relationship
3.
J Biomol Screen ; 14(4): 360-70, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19403919

ABSTRACT

Novel fluorescent derivatives of serotonin have been synthesized and used as tracers for the development of a 5-HT2C fluorescence polarization assay. Serotonin analogs that feature a fluorescent probe attached through an ether linkage at the tryptamine 5-position have high affinity for the 5-HT2C receptor, and affinity is dependent on both linker length and pendent dye. These variables have been optimized to generate Cy3B derivative 5a, which has 10-fold higher 5-HT2C affinity relative to serotonin (Kd=0.23 nM). In receptor activation experiments, 5a acts as a full agonist of 5-HT2C. Upon binding to 5-HT2C cell membranes, 5a shows a robust increase in fluorescence polarization (FP) signal. In an FP binding assay using 5a as a tracer ligand, Ki values for known 5-HT2C agonists and antagonists showed excellent agreement with Ki values from radioligand binding (r2=0.93). The FP ligand assay is suitable for high-throughput drug screening applications with respect to speed of analysis, displaceable signal, precision, and sensitivity to various reagents. A 384-well-based high-throughput assay that is rapid, economical, and predictive of test compounds' ability to bind to the 5-HT2C receptor has been compiled and validated.


Subject(s)
Drug Design , Fluorescent Dyes/metabolism , Receptor, Serotonin, 5-HT2C/analysis , Serotonin/analogs & derivatives , Staining and Labeling , Animals , Biological Assay , Fluorescence Polarization , Humans , Kinetics , Mice , NIH 3T3 Cells , Receptor, Serotonin, 5-HT2C/metabolism , Reference Standards , Reproducibility of Results , Structure-Activity Relationship
4.
J Vis Exp ; (119)2017 01 18.
Article in English | MEDLINE | ID: mdl-28190060

ABSTRACT

We present an open source high content analysis instrument utilizing automated fluorescence lifetime imaging (FLIM) for assaying protein interactions using Förster resonance energy transfer (FRET) based readouts of fixed or live cells in multiwell plates. This provides a means to screen for cell signaling processes read out using intramolecular FRET biosensors or intermolecular FRET of protein interactions such as oligomerization or heterodimerization, which can be used to identify binding partners. We describe here the functionality of this automated multiwell plate FLIM instrumentation and present exemplar data from our studies of HIV Gag protein oligomerization and a time course of a FRET biosensor in live cells. A detailed description of the practical implementation is then provided with reference to a list of hardware components and a description of the open source data acquisition software written in µManager. The application of FLIMfit, an open source MATLAB-based client for the OMERO platform, to analyze arrays of multiwell plate FLIM data is also presented. The protocols for imaging fixed and live cells are outlined and a demonstration of an automated multiwell plate FLIM experiment using cells expressing fluorescent protein-based FRET constructs is presented. This is complemented by a walk-through of the data analysis for this specific FLIM FRET data set.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Microscopy, Fluorescence/methods , Animals , Biosensing Techniques , COS Cells , Chlorocebus aethiops , Humans , Optical Imaging , Software , gag Gene Products, Human Immunodeficiency Virus/chemistry
5.
J Biomol Screen ; 10(6): 573-80, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16103412

ABSTRACT

Small molecule screening, the systematic encounter of biology space with chemical space, has provoked the emergence of a whole industry that recreates itself by constant iterative improvements to this process. The authors describe an approach to tackle the problem for one of the most time-consuming steps in the execution of a screening campaign, namely, the reformatting of high-throughput screening test compounds from master plates to daughter assay plates used in the execution of the screen. Through an engineered storage procedure, they prepare plates ahead of the screening process with the respective compounds in a ready-to-use format. They show the biological inertness of the method and how it facilitates efficient recovery of compound activity. This uncoupling of normally interconnected processes provides time and compound savings, avoids repeated freeze-thaw cycles of compound solutions, and removes the problems associated with the DMSO sensitivity of certain assays types.


Subject(s)
Chemistry, Pharmaceutical/methods , Drug Evaluation, Preclinical/methods , Automation , Chromatography, Liquid , Combinatorial Chemistry Techniques , Drug Stability , Drug Storage/methods , Inhibitory Concentration 50 , Mass Spectrometry , Models, Chemical , Molecular Weight , Nanotechnology , Pharmaceutical Preparations , Solubility , Specimen Handling , Temperature , Time Factors
6.
Curr Drug Discov Technol ; 1(1): 27-35, 2004 Jan.
Article in English | MEDLINE | ID: mdl-16472217

ABSTRACT

Driven by growing corporate compound files, the demands of target biology, and attempts to cut cost, the number of solutions to HTS has spiralled. In quick succession new assay technologies and screening platforms are appearing on the market, with the promise of screening faster than ever in low volume high density formats whilst providing high quality data. Within this world of rapid change, Pfizer has applied cutting edge technology to HTS by introducing screening in 1 microl formats utilising single molecule detection technology. Instead of resource intensive in-house development, Pfizer entered into a collaboration with Evotec OAI / Evotec Technologies and introduced their Mark-II EVOscreen platform. In this article we will outline the benefits of the approach taken at Pfizer, Sandwich, and introduce the Mark-II EVOscreen platform, illustrating the potential but also possible pitfalls of HTS miniaturisation.


Subject(s)
Drug Evaluation, Preclinical/methods , Technology, Pharmaceutical , Cloning, Molecular , Data Interpretation, Statistical , Drug Evaluation, Preclinical/economics , Fluorescence Polarization , Fluorescent Dyes , Indicators and Reagents , Nanotechnology , Phosphotransferases/analysis , Phosphotransferases/metabolism
7.
J Biophotonics ; 6(5): 398-408, 2013 May.
Article in English | MEDLINE | ID: mdl-23184449

ABSTRACT

Fluorescence lifetime measurements can provide quantitative readouts of local fluorophore environment and can be applied to biomolecular interactions via Förster resonant energy transfer (FRET). Fluorescence lifetime imaging (FLIM) can therefore provide a high content analysis (HCA) modality to map protein-protein interactions (PPIs) with applications in drug discovery, systems biology and basic research. We present here an automated multiwell plate reader able to perform rapid unsupervised optically sectioned FLIM of fixed and live biological samples and illustrate its potential to assay PPIs through application to Gag protein aggregation during the HIV life cycle. We demonstrate both hetero-FRET and homo-FRET readouts of protein aggregation and report the first quantitative evaluation of a FLIM HCA assay by generating dose response curves through addition of an inhibitor of Gag myristoylation. Z' factors exceeding 0.6 are realised for this FLIM FRET assay.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Molecular Imaging/methods , Protein Multimerization , gag Gene Products, Human Immunodeficiency Virus/chemistry , Automation , HeLa Cells , Humans , Protein Structure, Quaternary
SELECTION OF CITATIONS
SEARCH DETAIL